Health system strengthening evaluations 2013-2015

in page functions

Gavi’s health system strengthening (HSS) support is regularly evaluated to provide valuable insights into the HSS programme

HSS META-REVIEW

To ensure improved learning from and accountability of HSS grants, Gavi commissioned its first HSS meta-review in 2015. The review covers all 14 country HSS evaluations completed in the 2013–2015 period. Findings from the review will help inform future HSS grants as well as other types of Gavi support.

The objectives of the HSS meta-review are to:

  • synthesise findings regarding Gavi HSS grants (including relevance, implementation, effectiveness, efficiency, results and sustainability) and assess their robustness;
  • assess the extent to which Gavi HSS grants have complemented other resources at the country level (if information is available);
  • assess the extent to which challenges identified have been addressed through modifications to Gavi’s approach to HSS over time and make recommendations for additional improvements; and
  • help countries and the Vaccine Alliance in their ongoing efforts to improve the HSS support window, with particular focus on implementation.

HSS evaluation reports included in the meta-review:

Gavi-managed evaluations  

Country-managed evaluations  

Burkina Faso 

Cameroon 

Chad 

Ethiopia 

Madagascar 

Nepal 

Tajikistan 

Somalia 

Afghanistan 

Eritrea 

Ghana 

Myanmar (mid-term review)

Sudan 

Yemen 


 

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

More facts...

close icon

modal window here